ANAVEX LIFE SCIENCES CORP. Notes Payable, Current
ANAVEX LIFE SCIENCES CORP. (AVXL) had Notes Payable, Current of $87.89 thousand as of 2016-06-30, per its 10-Q filed 2016-08-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2016-12-14
- 2016-06-30: Notes Payable, Current $87.89K.
- 2016-03-31: Notes Payable, Current $88.14K.
- 2015-12-31: Notes Payable, Current $82.41K.
- 2015-09-30: Notes Payable, Current $85.24K.
| Period end | Notes Payable, Current |
|---|---|
| 2016-06-30 | $87.89K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $88.14K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $82.41K 10-Q · filed 2016-02-08 |
| 2015-09-30 | $85.24K 10-K · filed 2016-12-14 |
| 2015-06-30 | $92.52K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $90.41K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $98.31K 10-Q · filed 2015-02-17 |
| 2014-09-30 | $192.06K 10-K · filed 2015-12-29 |
| 2014-06-30 | $200.84K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $193.72K 10-Q/A · filed 2014-05-30 |
| 2013-12-31 | $200.36K 10-Q · filed 2014-02-14 |
| 2013-09-30 | $210.86K 10-K · filed 2014-12-29 |
| 2013-06-30 | $757.60K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $761.29K 10-Q · filed 2013-05-17 |
| 2012-12-31 | $599.00K 10-Q · filed 2013-02-14 |
| 2012-09-30 | $299.00K 10-K · filed 2013-12-30 |
| 2012-06-30 | $49.00K 10-Q · filed 2012-08-17 |
| 2012-03-31 | $1.20M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $1.16M 10-Q · filed 2012-02-14 |
| 2011-09-30 | $867.92K 10-K · filed 2012-12-31 |
| 2011-06-30 | $827.90K 10-Q · filed 2011-08-12 |
| 2010-09-30 | $2.49M 10-K · filed 2011-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |